Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) - Equities researchers at DA Davidson issued their Q1 2025 earnings estimates for Nu Skin Enterprises in a report released on Tuesday, February 18th. DA Davidson analyst C. Xue expects that the company will post earnings per share of $0.05 for the quarter. DA Davidson has a "Neutral" rating and a $7.00 price objective on the stock. The consensus estimate for Nu Skin Enterprises' current full-year earnings is $0.79 per share. DA Davidson also issued estimates for Nu Skin Enterprises' FY2026 earnings at $0.47 EPS.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.14. The company had revenue of $445.55 million during the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%.
Separately, StockNews.com downgraded shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Monday.
View Our Latest Report on NUS
Nu Skin Enterprises Stock Down 1.5 %
NUS traded down $0.12 during trading on Thursday, hitting $7.61. The stock had a trading volume of 715,988 shares, compared to its average volume of 821,632. The company has a market capitalization of $378.39 million, a PE ratio of -2.58 and a beta of 1.17. Nu Skin Enterprises has a twelve month low of $5.95 and a twelve month high of $14.04. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82. The stock has a 50 day simple moving average of $6.88 and a two-hundred day simple moving average of $7.37.
Nu Skin Enterprises Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 5th. Stockholders of record on Monday, February 24th will be paid a dividend of $0.06 per share. The ex-dividend date is Monday, February 24th. This represents a $0.24 annualized dividend and a dividend yield of 3.15%. Nu Skin Enterprises's payout ratio is currently -8.14%.
Institutional Investors Weigh In On Nu Skin Enterprises
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Mackenzie Financial Corp lifted its stake in shares of Nu Skin Enterprises by 406.1% during the fourth quarter. Mackenzie Financial Corp now owns 60,595 shares of the company's stock worth $418,000 after buying an additional 48,621 shares during the period. Public Employees Retirement System of Ohio lifted its stake in shares of Nu Skin Enterprises by 28.5% during the fourth quarter. Public Employees Retirement System of Ohio now owns 7,976 shares of the company's stock worth $55,000 after buying an additional 1,768 shares during the period. PharVision Advisers LLC acquired a new stake in shares of Nu Skin Enterprises during the fourth quarter worth $561,000. Squarepoint Ops LLC lifted its stake in shares of Nu Skin Enterprises by 31.0% during the fourth quarter. Squarepoint Ops LLC now owns 180,151 shares of the company's stock worth $1,241,000 after buying an additional 42,601 shares during the period. Finally, Two Sigma Advisers LP lifted its stake in shares of Nu Skin Enterprises by 61.2% during the fourth quarter. Two Sigma Advisers LP now owns 944,000 shares of the company's stock worth $6,504,000 after buying an additional 358,400 shares during the period. 82.84% of the stock is currently owned by institutional investors and hedge funds.
Nu Skin Enterprises Company Profile
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.